Atlas Trials

Phase 1 PK Interaction Study Between VX-509 and Prednisone or Methylprednisolone in Healthy Male Subjects

Clinical trial NCT01886209 · COMPLETED

Trial details

NCT number
NCT01886209
Sponsor
Vertex Pharmaceuticals Incorporated
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Drug Interactions
Start date
2013-06-01
Primary completion
2013-08-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.